Equipment to measure severity of coronavirus patients

Equipment to measure severity of coronavirus patients

Photo taken in Kyoto on March 29, 2021, shows medical equipment announced by precision instrument maker Shimadzu Corp. the same day to predict whether a coronavirus patient will eventually develop severe symptoms. The equipment, developed jointly with Kumamoto University and AiSTI SCIENCE Co., and planned to be sold in June at the earliest, is capable of predicting the severity of the disease possibly within six minutes using the patient's blood or urine.

  • Product Code
  • ILEA000057125
  • Registered date
  • 2021/3/29 18:58:46
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2021 Kyodo News
  • Media size
  • 3968 × 2639 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 940.66(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Low-price PCR testing device

    Low-price PCR testing device

    Japanese precision equipment maker Shimadzu Corp. announces the launch of its fully automated PCR testing device in Kyoto on Nov. 27, 2020, amid the coronavirus pandemic. The device, which measures 66 centimeters in height, 30 cm in width and 65 cm in length, costs 2.09 million yen ($20,100).
      Low-price PCR testing device

      Low-price PCR testing device

      Japanese precision equipment maker Shimadzu Corp. announces the launch of its fully automated PCR testing device in Kyoto on Nov. 27, 2020, amid the coronavirus pandemic. The device, which measures 66 centimeters in height, 30 cm in width and 65 cm in length, costs 2.09 million yen ($20,100).
        Double Giken's Communication Tool for ALS Patients

        Double Giken's Communication Tool for ALS Patients

        Double Giken has developed a technology to identify the words a patient thinks from the blood flow in the brain and project them on a screen for ALS patients who cannot move their eyelids or fingers. The technology is based on a device that uses near-infrared spectroscopy (NIRS) to determine "yes/no" from brain activity. The patient selects one word at a time and only the vowel sound of the word to be communicated, and the number of words is used to analogize the candidate words to be communicated and show them on the screen. The system, which consists of a personal computer and a terminal, will go on sale in September at the earliest. It was developed with the support of the New Energy and Industrial Technology Development Organization (NEDO) in collaboration with Professor Naoki Tanaka of Toyo University and others. Photo taken on June 4, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images
          Nobel laureate Tanaka speaks at Stockholm Univ.

          Nobel laureate Tanaka speaks at Stockholm Univ.

          STOCKHOLM, Sweden - Koichi Tanaka, co-winner of the 2002 Nobel Prize in Chemistry, speaks Dec. 8 at Stockholm University ahead of the awards ceremony Dec. 10. Tanaka, 43, a senior engineer at Kyoto-based precision equipment maker Shimadzu Corp., explained the origin of macromolecule ionization through lasers. (Kyodo)
            Shimadzu to sell needle-free insulin injector

            Shimadzu to sell needle-free insulin injector

            OSAKA, Japan - Shimadzu Corp., a comprehensive precision equipment maker, said it will begin selling on Sept. 13 a needle-free device (photo) to inject insulin into diabetes patients. The device, called Shima JET, has a plastic nozzle instead of a needle through which insulin is injected into a patient by means of spring-generated pressure, Shimadzu said, adding it therefore does not cause as much pain as a needle. The Kyoto-based company will market Shima JET to hospitals and other medical institutions for 80,000 yen.